Home › Chronic Lymphocytic Leukemia › Oregon › Eugene
Pag-aaral pangklinika para sa Chronic Lymphocytic Leukemia sa Eugene, OR
Isang pag-aaral para sa Chronic Lymphocytic Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Eugene. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Nagre-recruitPhase 3
- Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Nagre-recruitPhase 3
- Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
Nagre-recruitPhase 3
- Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
Nagre-recruitPhase 1/2
- Oncology Associates of Oregon, Eugene
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Nagre-recruitPhase 3
- Willamette Valley Cancer Center, Eugene
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Nagre-recruitPhase 2
- Williamette Valley Cancer Institute & Research Center, Eugene
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Nagre-recruitPhase 3
- Willamette Valley Cancer Institute and Research Center /ID# 266326, Eugene
Pag-aaral para sa Chronic Lymphocytic Leukemia sa ibang lungsod
- Boston, MA31 pag-aaral
- Columbus, OH29 pag-aaral
- Durham, NC27 pag-aaral
- Washington, DC22 pag-aaral
- Seattle, WA21 pag-aaral
- Rochester, MN19 pag-aaral
- New York City, NY18 pag-aaral
- Houston, TX17 pag-aaral
- Baldwin Park, CA16 pag-aaral
- Milwaukee, WI14 pag-aaral
- Chicago, IL14 pag-aaral
- Cincinnati, OH14 pag-aaral
Iba pang pag-aaral sa Eugene
- Non-Small Cell Lung Cancer13 pag-aaral
- Kanser sa Ovary9 pag-aaral
- Kanser ng Endometrium8 pag-aaral
- Kanser sa Suso7 pag-aaral
- Metastatic Cancer6 pag-aaral
- Kanser (lahat ng uri)6 pag-aaral
- Multiple Myeloma6 pag-aaral
- Kanser sa Baga5 pag-aaral
- Degenerasyon ng Macula5 pag-aaral
- Paggamit ng Gamot at Adiksyon5 pag-aaral
- Obesity4 pag-aaral
- Wet Macular Degeneration3 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.